Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial
Author:
Publisher
Elsevier BV
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference25 articles.
1. Two-year health outcomes in hospitalized COVID-19 survivors in China;Yang;JAMA Netw Open,2022
2. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients;Taquet;Lancet Psychiatr,2022
3. Sustained abnormality with recovery of COVID-19 convalescents: a 2-year follow-up study;Lin;Sci Bull,2022
4. Therapeutic advances in COVID-19;Murakami;Nat Rev Nephrol,2022
5. Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia;Leng;Aging Dis,2020
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pathogen evolution, prevention/control strategy and clinical features of COVID-19: experiences from China;Frontiers of Medicine;2023-12-29
2. Mesenchymal stem cell therapy for COVID-19 infection;Inflammopharmacology;2023-12-20
3. MSC-Based Cell Therapy for COVID-19-Associated ARDS and Classical ARDS: Comparative Perspectives;Current Stem Cell Reports;2023-12-06
4. Update on the Use of Mesenchymal Stem Cells in the Treatment of Various Infectious Diseases Including COVID-19 Infection;Journal of Stem Cell Therapy and Transplantation;2023-12-05
5. Epitranscriptomic modifications in mesenchymal stem cell differentiation: advances, mechanistic insights, and beyond;Cell Death & Differentiation;2023-11-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3